Sharekhan

GKB Ophthalmics Ltd

Thu 29/01/2015,0:0:0 NSE: GKB

₹ 84.05 0.00 (0.00%)
BUY NOW Buy GKB Ophthalmics Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock GKB Ophthalmics Ltd

Wed 21/05/2025,16:1:0

GKB Ophthalmics Ltd

Thu 29/01/2015,0:0:0 | NSE : GKB

₹ 84.050.00 (0.00%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 84.50

Previous Close

₹ 84.05

Volume

83081

Mkt Cap ( Rs. Cr)

₹42.37

High

₹ 90.90

Low

₹ 84.00

52 Week High

₹ 131.75

52 Week Low

₹ 59.00

Book Value Per Share

₹ 115.43

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on GKB Ophthalmics Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts GKB Ophthalmics Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • GKB Ophthalmic - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results For The Quart

    14 May 2025, 4:06PM GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and

  • GKB Ophthalmic - Intimation Of Change In Contact Details Of Registrar And Share Transfer Agent (\RTA\) Of The Company

    21 Apr 2025, 11:39AM We wish to inform that MUFG Intime India Private Limited ('MUFG') has intimated the company about the change in email address and website as under:\r

  • GKB Ophthalmic has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    15 Apr 2025, 7:00AM As of March 2025, 50.99% is owned by Indian Promoters and 49.01% by Public. <p align=justify> Top five Promoters holding highest number of shares of G

  • GKB Ophthalmic - Non Applicability Of Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26, 2018.

    10 Apr 2025, 4:00PM Pursuant to Circular No. SEBI/HO/DDHS/CIR/P/2018/144, dated November 26, 1018, issued by the Securities Exchange Board of India, we hereby confirm tha

  • GKB Ophthalmic - Announcement under Regulation 30 (LODR)-Credit Rating

    9 Apr 2025, 4:56PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations , 2015 , we hereby inform that CRISIL Rating Limited (

  • GKB Ophthalmic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Apr 2025, 4:14PM Please find herewith Certificate under Regulation 74(5) of SEBI ( Depositories and Participants) Regulations, 2018 , for the quarter ended March 31, 2

  • GKB Ophthalmic - Disclosure Under Regulations 31 (4) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 20

    2 Apr 2025, 3:49PM Please find enclosed herewith the disclosure under Regulation 31 (4) of Securities and exchange Board of India (Substantial Acquisition of Shares and

  • GKB Ophthalmic - Intimation Under Regulation 30 Of SEBI( Listing Obligations And Disclosure Requirements) Regulation , 2015-

    31 Mar 2025, 4:31PM In compliance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform

  • GKB Ophthalmic - Outcome Of Independent Directors' Meeting Held On March 27, 2025.

    27 Mar 2025, 4:04PM A separate meeting of the Independent directors of the Company for the year 2024-25, was held, pursuant to Regulation 25(3) of SEBI(Listing Obligation

  • GKB Ophthalmic - Outcome Of Independent Directors' Meeting Held On March 27, 2025.

    27 Mar 2025, 4:04PM A separate meeting of the Independent directors of the Company for the year 2024-25, was held, pursuant to Regulation 25(3) of SEBI(Listing Obligation

  • GKB Ophthalmic - Outcome Of Independent Directors' Meeting Held On March 27, 2025.

    27 Mar 2025, 4:04PM A separate meeting of the Independent directors of the Company for the year 2024-25, was held, pursuant to Regulation 25(3) of SEBI(Listing Obligation

  • GKB Ophthalmic - Outcome Of Independent Directors' Meeting Held On March 27, 2025.

    27 Mar 2025, 4:04PM A separate meeting of the Independent directors of the Company for the year 2024-25, was held, pursuant to Regulation 25(3) of SEBI(Listing Obligation

  • GKB Ophthalmic - Outcome Of Independent Directors' Meeting Held On March 27, 2025.

    27 Mar 2025, 4:04PM A separate meeting of the Independent directors of the Company for the year 2024-25, was held, pursuant to Regulation 25(3) of SEBI(Listing Obligation

  • GKB Ophthalmic - Outcome Of Independent Directors' Meeting Held On March 27, 2025.

    27 Mar 2025, 4:04PM A separate meeting of the Independent directors of the Company for the year 2024-25, was held, pursuant to Regulation 25(3) of SEBI(Listing Obligation

  • GKB Ophthalmic - Outcome Of Independent Directors' Meeting Held On March 27, 2025.

    27 Mar 2025, 4:04PM A separate meeting of the Independent directors of the Company for the year 2024-25, was held, pursuant to Regulation 25(3) of SEBI(Listing Obligation

  • GKB Ophthalmic - Outcome Of Independent Directors' Meeting Held On March 27, 2025.

    27 Mar 2025, 4:04PM A separate meeting of the Independent directors of the Company for the year 2024-25, was held, pursuant to Regulation 25(3) of SEBI(Listing Obligation

  • GKB Ophthalmic - Notice Of The Independent Directors' Meeting

    18 Mar 2025, 5:01PM Notice is hereby given that pursuant to Regulation 25 (3 and 4) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 and Schedule

  • GKB Ophthalmic - Notice Of The Independent Directors' Meeting

    18 Mar 2025, 5:01PM Notice is hereby given that pursuant to Regulation 25 (3 and 4) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 and Schedule

  • GKB Ophthalmic - Notice Of The Independent Directors' Meeting

    18 Mar 2025, 5:01PM Notice is hereby given that pursuant to Regulation 25 (3 and 4) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 and Schedule

  • GKB Ophthalmic - Notice Of The Independent Directors' Meeting

    18 Mar 2025, 5:01PM Notice is hereby given that pursuant to Regulation 25 (3 and 4) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 and Schedule

  • GKB Ophthalmic - Notice Of The Independent Directors' Meeting

    18 Mar 2025, 5:01PM Notice is hereby given that pursuant to Regulation 25 (3 and 4) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 and Schedule
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of GKB Ophthalmics Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 35.065 38.7324 42.1585 44.0878 45.2412
Liabilities 35.065 38.7324 42.1585 44.0878 45.2412
Equity 5.0406 5.0406 5.0406 5.0405 5.0405
Gross Profit -1.2743 -1.0957 -0.4465 -0.5736 -0.811
Net Profit -3.4164 -2.8813 -2.3103 -2.1079 -4.1716
Cash From Operating Activities 1.3633 -1.1449 2.3304 2.108 6.1125
NPM(%) -10.95 -10.39 -8.54 -9.87 -16.37
Revenue 31.1805 27.7293 27.0482 21.3431 25.4822
Expenses 32.4548 28.825 27.4947 21.9168 26.2933
ROE(%) -5.87 -4.95 -3.97 -3.62 -7.16

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
21 Sep 2010 1.2 12 0 51.05

Peers

Other companies within the same industry or sector that are comparable to GKB Ophthalmics Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nureca Ltd 251.22 2.00 299.07 74.04 8.46 0.00
Procter and Gamble Hygiene and Healthcare Ltd 14187.00 -0.47 64.33 240.33 2079.50 1.80
Godrej Industries Ltd 1160.40 0.30 39.82 2492.93 2914.25 0.00
Colgate-Palmolive (India) Ltd 2659.30 1.14 49.48 2013.78 4866.65 2.18

Company Info

GKB Ophthalmics Limited was incorporated on 10th Dec. 1981. The company was granted a licence as a 100% E.O.U. in 1982. The factory at Tivim Industrial Estate, Tivim, Goa was set up financial assistance from the Economic Development Corporation of Goa, Daman and Diu Ltd. and the The Maharashtra State Financial Corporation. The company is engaged in the manufacture and export of high quality, single-vision mineral Ophthalmic lenses at Mapusa-Goa and commenced commercial production in May, 1983. The Company has been consistently earning profits and paying dividend since 1988-89. The company has a total installed capacity of 13 lac lenses per annum. The company's plant is equipped with the most advanced and sophisticated West German technology for manufacture of lenses. The plant has adequate production facilities and quality control systems to ensure high precision in the lenses manufactured by them. As a result GKB products have a good reputation in the field of ophthalmics. The company has consistently earned the distinction of winning the Chemicals and Allied Products Export Promotion Council's (CAPEXCIL) Export Certificate of Merity year after year for the past eleven years i.e. from 1983-84 to 1993-94 in recognition of their export achievement in respect of ophthalmic lenses. In 1992-93, the Company also received an award from the Confederation of the Export Units (CEU) for the best performance in ophthalmic lenses. 2000 -The company declares 12% interim dividend. 2003 -Rodenstock in alliance with GKB to manufacture lens 2008 -The Goa-based GKB Ophthalmics Ltd has inked an alliance agreement with Spain-based multinational company Indo to market the latter's high-end optical and ophthalmic products, comprising high precision equipment, in the Indian and Asian markets. 2010 -GKB Ophthalmics gets its shares listed on the Exchange in the list of 'B' Group Securities. -The company ahs designated E-mail Id for investor complaints: investor.grievance@gkb.net 2011 - GKB Ophthalmics Ltd has appointed Mr. Joseph A.A. Dcosta as a additional Non Executive Independent Director.

GKB Ophthalmics Limited was incorporated on 10th Dec. 1981. The company was granted a licence as a 100% E.O.U. in 1982. The factory at Tivim Industrial Estate, Tivim, Goa was set up financial assistance from the Economic Development Corporation of Goa, Daman and Diu Ltd. and the The Maharashtra State Financial Corporation. The company is engaged in the manufacture and export of high quality, single-vision mineral Ophthalmic lenses at Mapusa-Goa and commenced commercial production in May, 1983. The Company has been consistently earning profits and paying dividend since 1988-89. The company has a total installed capacity of 13 lac lenses per annum. The company's plant is equipped with the most advanced and sophisticated West German technology for manufacture of lenses. The plant has adequate production facilities and quality control systems to ensure high precision in the lenses manufactured by them. As a result GKB products have a good reputation in the field of ophthalmics. The company has consistently earned the distinction of winning the Chemicals and Allied Products Export Promotion Council's (CAPEXCIL) Export Certificate of Merity year after year for the past eleven years i.e. from 1983-84 to 1993-94 in recognition of their export achievement in respect of ophthalmic lenses. In 1992-93, the Company also received an award from the Confederation of the Export Units (CEU) for the best performance in ophthalmic lenses. 2000 -The company declares 12% interim dividend. 2003 -Rodenstock in alliance with GKB to manufacture lens 2008 -The Goa-based GKB Ophthalmics Ltd has inked an alliance agreement with Spain-based multinational company Indo to market the latter's high-end optical and ophthalmic products, comprising high precision equipment, in the Indian and Asian markets. 2010 -GKB Ophthalmics gets its shares listed on the Exchange in the list of 'B' Group Securities. -The company ahs designated E-mail Id for investor complaints: investor.grievance@gkb.net 2011 - GKB Ophthalmics Ltd has appointed Mr. Joseph A.A. Dcosta as a additional Non Executive Independent Director.

Read More

Parent Organisation

GKB Ophthalmics Ltd.

Founded

10/12/1981

Managing Director

Mr.K G Gupta

NSE Symbol

GKBEQ

FAQ

The current price of GKB Ophthalmics Ltd is ₹ 84.05.

The 52-week high for GKB Ophthalmics Ltd is ₹ 90.90 and the 52-week low is ₹ 84.00.

The market capitalization of GKB Ophthalmics Ltd is currently ₹ 42.37. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy GKB Ophthalmics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in GKB Ophthalmics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase GKB Ophthalmics Ltd shares.

The CEO of GKB Ophthalmics Ltd is Mr.K G Gupta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT